DEFA14A ·Filed Apr 15, 2026
Proxy solicitation materials
Actionable Insight • Neutral
Monitor for the release of the full proxy statement to understand the specific proposals and voting recommendations. The current metadata does not provide enough information to assess the impact of the shareholder vote.
Final — all horizons settled through T+60d
ADMA ▼ -16.48% at T+60d
NEUTRAL call -16.48% · α vs SPY -23.53% · entry $10.74 → $8.97
T+1d
+2.51%
call +2.51% · α +1.30%
$11.01
settled 6mo ago
T+5d
+3.17%
call +3.17% · α +2.18%
$11.08
settled 6mo ago
T+20d
-20.86%
call -20.86% · α -26.67%
$8.50
settled 6mo ago
T+60d
-16.48%
call -16.48% · α -23.53%
$8.97
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Key Facts
- The filing is a DEFA14A, which is a definitive proxy statement related to a shareholder vote.
- The company is ADMA BIOLOGICS, INC., trading under the ticker ADMA.
- The filing type indicates it is related to a shareholder vote, but no specific details about the vote are available from the provided documents.
Financial Impact
No financial impact data available
Risk Factors
- Lack of detailed information may lead to uncertainty in investor sentiment.
- The absence of financial data makes it difficult to assess the potential impact on the company's stock price.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-014801 |
| Document: 0001140361-26-014801-index-headers.html | 0001140361-26-014801 |
| Document: 0001140361-26-014801-index.html | 0001140361-26-014801 |
| Document: 0001140361-26-014801.txt | 0001140361-26-014801 |
7 reports for ADMA
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | Press Release | $10.73 | awaiting T+60 | — | $11.09 (+3.31%) |
Aug 8, 2026 11w ago | Institutional Cluster | $9.75 | awaiting T+60 | — | $11.09 (+13.69%) |
Jun 11, 2026 19w ago | Institutional Cluster | $8.21 $9.54 | ▲ +16.20% | ▲ +12.94% | $11.09 (+35.02%) |
May 4, 2026 25w ago | 8-K | $10.31 $8.71 | ▼ −15.52% | ▼ −17.38% | $11.09 (+7.52%) |
Apr 15, 2026 27w ago | DEFA14A | $10.74 $8.97 | ▼ −16.48% | ▼ −23.53% | $11.09 (+3.21%) |
Mar 27, 2026 30w ago | Press Release | $9.25 $8.72 | ▼ −5.78% | ▼ −21.85% | $11.09 (+19.84%) |
Feb 25, 2026 34w ago | 8-K | $15.18 $8.46 | ▼ −44.27% | ▼ −52.02% | $11.09 (−26.98%) |
Showing 7 of 7
US Market Status
Market Open — Closes in 4h 6m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers